Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

Overview of attention for article published in Journal of Clinical Oncology, August 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 21 X users
facebook: 2 Facebook pages

bluesky: 3 Bluesky users

Readers on

mendeley: 16 Mendeley

So far, Altmetric has seen 23 X posts from 21 X users, with an upper bound of 67,326 followers.

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials https://t.co/WPfE7ggJB0 #ScientiaVH

Mifamurtide boosts survival in high-grade osteosarcoma patients, particularly those with Pgp-positive tumors, in a risk-adapted approach. by Palmerini E, Meazza C (...) Broto JM et 28 al. in J Clin Oncol https://t.co/x18W4inNXF #MedX #MedResearch

La Dra. E. Palmerini (ISG / Rizzoli) junto a GEIS analiza el papel de mifamurtide en osteosarcoma localizado. 📊 Pacientes Pgp+ con MAP+mifamurtide: EFS 5 años = 71.4 % vs. 58.3 % con solo quimio (p=0.0139). Un paso hacia terapias personalizadas. http…

RT @VivekSubbiah: Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 19 additional X posts.